On the duration of the period between exposure to HIV and detectable infection

Epidemics

Volumn 20, Issue , 2017, Pages 73-83

  Konrad, Bernhard P ^a   Taylor, Darlene ^b   Conway, Jessica M ^c   Ogilvie, Gina S ^b   Coombs, Daniel ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Eclipse period; HIV; Stochastic modelling; Viral kinetics

Indexed keywords

VIRUS RNA;

ARTICLE; BLOOD DONOR; EXPOSURE; FALSE NEGATIVE RESULT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIMIT OF DETECTION; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; STOCHASTIC MODEL; VIRAL CLEARANCE; VIRION; VIRUS LOAD; BLOOD; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA; THEORETICAL MODEL; TIME FACTOR;

HIV INFECTIONS; HUMANS; MODELS, THEORETICAL; REPRODUCIBILITY OF RESULTS; TIME FACTORS; VIRAL LOAD;

EID: 85016505412     PISSN: 17554365     EISSN: 18780067     Source Type: Journal    
DOI: 10.1016/j.epidem.2017.03.002     Document Type: Article

References (49)

1. Abrahams, M.-R., Anderson, J.A., Giorgi, E.E., Seoighe, C., Mlisana, K., Ping, L.-H., Athreya, G.S., Treurnicht, F.K., Keele, B.F., Wood, N., Salazar-Gonzalez, J.F., Bhattacharya, T., Chu, H., Hoffman, I., Galvin, S., Mapanje, C., Kazembe, P., Thebus, R., Fiscus, S., Hide, W., Cohen, M.S., Karim, S.A., Haynes, B.F., Shaw, G.M., Hahn, B.H., Korber, B.T., Swanstrom, R., Williamson, C., CAPRISA Acute Infection Study Team, Center for HIV-AID Vaccine Immunology Consortium, Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J. Virol. 83:8 (2009), 3556–3567, 10.1128/JVI.02132-08.
2. Allen, T.M., Mortara, L., Mothé, B.R., Liebl, M., Jing, P., Calore, B., Piekarczyk, M., Ruddersdorf, R., O'Connor, D.H., Wang, X., Wang, C., Allison, D.B., Altman, J.D., Sette, A., Desrosiers, R.C., Sutter, G., Watkins, D.I., Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication. J. Virol. 76:8 (2002), 4108–4112.
3. Bar, K.J., Li, H., Chamberland, A., Tremblay, C., Routy, J.P., Grayson, T., Sun, C., Wang, S., Learn, G.H., Morgan, C.J., Schumacher, J.E., Haynes, B.F., Keele, B.F., Hahn, B.H., Shaw, G.M., Wide variation in the multiplicity of HIV-1 infection among injection drug users. J. Virol. 84:12 (2010), 6241–6247, 10.1128/JVI.00077-10.
4. Britton, T., Stochastic epidemic models: a survey. Math. Biosci. 225 (2010), 24–35.
5. Burgard, M., Blanche, S., Jasseron, C., Descamps, P., Allemon, M.-C., Ciraru-Vigneron, N., Floch, C., Heller-Roussin, B., Lachassinne, E., Mazy, F., Warszawski, J., Rouzioux, C., Agence Nationale de Recherche sur le SIDA et les Hepatites virales French Perinatal Cohort, Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis. J. Pediatr., 160(1), 2012, 60-6.e1, 10.1016/j.jpeds.2011.06.053.
6. Carias, A.M., McCoombe, S., McRaven, M., Anderson, M., Galloway, N., Vandergrift, N., Fought, A.J., Lurain, J., Duplantis, M., Veazey, R.S., Hope, T.J., Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract. J. Virol. 87:21 (2013), 11388–11400, 10.1128/JVI.01377-13.
7. Chen, H.Y., Di Mascio, M., Perelson, A.S., Ho, D.D., Zhang, L., Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques. Proc. Natl. Acad. Sci. U. S. A. 104:48 (2007), 19079–19084.
8. Conway, J.M., Coombs, D., A stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patients. PLoS Comp. Biol., 7(4), 2011, e1002033.
9. Conway, J.M., Konrad, B.P., Coombs, D., Stochastic analysis of pre-and postexposure prophylaxis against HIV infection. SIAM J. Appl. Math. 73:2 (2013), 904–928.
10. de Boer, R.J., Ribeiro, R.M., Perelson, A.S., Current estimates for HIV-1 production imply rapid viral clearance in lymphoid tissues. PLoS Comput. Biol., 6(9), 2010, e1000906, 10.1371/journal.pcbi.1000906.
11. Dixit, N.M., Markowitz, M., Ho, D.D., Perelson, A.S., Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy. Antivir. Ther. 9 (2004), 237–246.
12. Fiebig, E.W., Wright, D.J., Rawal, B.D., Garrett, P.E., Schumacher, R.T., Peddada, L., Heldebrant, C., Smith, R., Conrad, A., Kleinman, S.H., Busch, M.P., Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:13 (2003), 1871–1879, 10.1097/01.aids.0000076308.76477.b8.
13. Gray, R.H., Wawer, M.J., Brookmeyer, R., Sewankambo, N.K., Serwadda, D., Wabwire-Mangen, F., Lutalo, T., Li, X., VanCott, T., Quinn, T.C., Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357:9263 (2001), 1149–1153.
14. Haaland, R.E., Hawkins, P.A., Salazar-Gonzalez, J., Johnson, A., Tichacek, A., Karita, E., Manigart, O., Mulenga, J., Keele, B.F., Shaw, G.M., Hahn, B.H., Allen, S.A., Derdeyn, C.A., Hunter, E., Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog., 5(1), 2009, e1000274, 10.1371/journal.ppat.1000274.
15. Haase, A., Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Ann. Rev. Immunol. 17:1 (1999), 625–656.
16. Haase, A.T., Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464:7286 (2010), 217–223.
17. Haase, A.T., Early events in sexual transmission of HIV and SIV and opportunities for interventions. Ann. Rev. Med. 62 (2011), 127–139.
18. Ickovics, J.R., Druley, J.A., Grigorenko, E.L., Morrill, A.C., Beren, S.E., Rodin, J., Long-term effects of HIV counseling and testing for women: behavioral and psychological consequences are limited at 18 months posttest. Health Psychol., 17(5), 1998, 395.
19. Joseph, H.A., Fasula, A.M., Morgan, R.L., Stuckey, A., Alvarez, M.E., Margolis, A., Stratford, D., Dooley, S.W. Jr., “The anticipation alone could kill you”: past and potential clients’ perspectives on HIV testing in non-health care settings. AIDS Educ. Prev. 23:6 (2011), 577–594.
20. Karlin, S., Taylor, H., A First Course in Stochastic Processes. 1975, Academic Press, New York.
21. Keele, B.F., Giorgi, E.E., Salazar-Gonzalez, J.F., Decker, J.M., Pham, K.T., Salazar, M.G., Sun, C., Grayson, T., Wang, S., Li, H., Wei, X., Jiang, C., Kirchherr, J.L., Gao, F., Anderson, J.A., Ping, L.-H., Swanstrom, R., Tomaras, G.D., Blattner, W.A., Goepfert, P.A., Kilby, J.M., Saag, M.S., Delwart, E.L., Busch, M.P., Cohen, M.S., Montefiori, D.C., Haynes, B.F., Gaschen, B., Athreya, G.S., Lee, H.Y., Wood, N., Seoighe, C., Perelson, A.S., Bhattacharya, T., Korber, B.T., Hahn, B.H., Shaw, G.M., Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 105:21 (2008), 7552–7557, 10.1073/pnas.0802203105.
22. Keele, B.F., Li, H., Learn, G.H., Hraber, P., Giorgi, E.E., Grayson, T., Sun, C., Chen, Y., Yeh, W.W., Letvin, N.L., Mascola, J.R., Nabel, G.J., Haynes, B.F., Bhattacharya, T., Perelson, A.S., Korber, B.T., Hahn, B.H., Shaw, G.M., Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J. Exp. Med. 206:5 (2009), 1117–1134, 10.1084/jem.20082831.
23. Konrad, B.P., On the Dynamics of HIV and Malaria Infection – Insights from Mathematical Models. 2015, University of British Columbia (Ph.D. thesis).
24. Landovitz, R., Occupational and nonoccupational postexposure prophylaxis for HIV in 2009. Top. HIV Med. 17:3 (2008), 104–108.
25. Larkin, J., Flicker, S., Koleszar-Green, R., Mintz, S., Dagnino, M., Mitchell, C., HIV risk, systemic inequities, and aboriginal youth: widening the circle for HIV prevention programming. Can J. Public Health, 2007, 179–182.
26. Lee, H.Y., Giorgi, E.E., Keele, B.F., Gaschen, B., Athreya, G.S., Salazar-Gonzalez, J.F., Pham, K.T., Goepfert, P.A., Kilby, J.M., Saag, M.S., Delwart, E.L., Busch, M.P., Hahn, B.H., Shaw, G.M., Korber, B.T., Bhattacharya, T., Perelson, A.S., Modeling sequence evolution in acute HIV-1 infection. J. Theor. Biol. 261:2 (2009), 341–360, 10.1016/j.jtbi.2009.07.038.
27. Li, H., Bar, K.J., Wang, S., Decker, J.M., Chen, Y., Sun, C., Salazar-Gonzalez, J.F., Salazar, M.G., Learn, G.H., Morgan, C.J., Schumacher, J.E., Hraber, P., Giorgi, E.E., Bhattacharya, T., Korber, B.T., Perelson, A.S., Eron, J.J., Cohen, M.S., Hicks, C.B., Haynes, B.F., Markowitz, M., Keele, B.F., Hahn, B.H., Shaw, G.M., High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog., 6(5), 2010, e1000890, 10.1371/journal.ppat.1000890.
28. Markowitz, M., Louie, M., Hurley, A., Sun, E., Di Mascio, M., Perelson, A.S., Ho, D.D., A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J. Virol. 77:8 (2003), 5037–5038.
29. McDermott, A.B., Mitchen, J., Piaskowski, S., De Souza, I., Yant, L.J., Stephany, J., Furlott, J., Watkins, D.I., Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates. J. Virol. 78:6 (2004), 3140–3144.
30. Nixon, D.F., Donahoe, S.M., Kakimoto, W.M., Samuel, R.V., Metzner, K.J., Gettie, A., Hanke, T., Marx, P.A., Connor, R.I., Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine. Virology 266:1 (2000), 203–210.
31. Noecker, C., Schaefer, K., Zaccheo, K., Yang, Y., Day, J., Ganusov, V.V., Simple mathematical models do not accurately predict early SIV dynamics. Viruses 7:3 (2015), 1189–1217, 10.3390/v7031189.
32. Obermeyer, C.M., Osborn, M., The utilization of testing and counseling for HIV: a review of the social and behavioral evidence. J. Inf., 97(10), 2007.
33. Ovaskainen, O., Meerson, B., Stochastic models of population extinction. Trends Ecol. Evol. 25:11 (2010), 643–652, 10.1016/j.tree.2010.07.009.
34. Patel, P., Borkowf, C.B., Brooks, J.T., Lasry, A., Lansky, A., Mermin, J., Estimating per-act HIV transmission risk: a systematic review. AIDS 28:10 (2014), 1509–1519.
35. Pearson, J.E., Krapivsky, P., Perelson, A.S., Stochastic theory of early viral infection: continuous versus burst production of virions. PLoS Comput. Biol., 7(2), 2011, e1001058, 10.1371/journal.pcbi.1001058.
36. Perelson, A.S., Ribeiro, R.M., Modeling the within-host dynamics of HIV infection. BMC Biol., 11(1), 2013, 96.
37. Perelson, A.S., Kirschner, D.E., De Boer, R., Dynamics of HIV infection of CD4+T cells. Math. Biosci. 114:1 (1993), 81–125.
38. Ramratnam, B., Bonhoeffer, S., Binley, J., Hurley, A., Zhang, L., Mittler, J.E., Markowitz, M., Moore, J.P., Perelson, A.S., Ho, D.D., Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 354:9192 (1999), 1782–1785.
39. Regoes, R.R., The role of exposure history on HIV acquisition: insights from repeated low-dose challenge studies. PLoS Comp. Biol., 8(11), 2012, e1002767.
40. Ribeiro, R.M., Qin, L., Chavez, L.L., Li, D., Self, S.G., Perelson, A.S., Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. J. Virol. 84:12 (2010), 6096–6102.
41. Sagar, M., Origin of the transmitted virus in HIV infection: infected cells versus cell-free virus. J. Infect. Dis. 210 (2014), S667–S673, 10.1093/infdis/jiu369.
42. Taylor, D., Durigon, M., Davis, H., Archibald, C., Konrad, B., Coombs, D., Gilbert, M., Cook, D., Krajden, M., Wong, T., Ogilvie, G., Probability of a false-negative HIV antibody test result during the window period: a tool for pre- and post-test counselling. Int. J. STD AIDS 26:4 (2015), 215–224, 10.1177/0956462414542987.
43. Vernazza, P.L., Eron, J.J., Fiscus, S.A., Cohen, M.S., Sexual transmission of HIV: infectiousness and prevention. AIDS 13:2 (1999), 155–166.
44. Wawer, M.J., Gray, R.H., Sewankambo, N.K., Serwadda, D., Li, X., Laeyendecker, O., Kiwanuka, N., Kigozi, G., Kiddugavu, M., Lutalo, T., Nalugoda, F., Wabwire-Mangen, F., Meehan, M.P., Quinn, T.C., Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 191:9 (2005), 1403–1409, 10.1086/429411.
45. WHO, Fact Sheet 1 HIV/AIDS: the infection, http://www.who.int/hiv/abouthiv/en/fact_sheet_hiv.htm, [Online; accessed 25-November-2014].
46. Worthington, C., Myers, T., Desired elements of HIV testing services: test recipient perspectives. AIDS Patient Care STDS 16:11 (2002), 537–548.
47. Worthington, C., Myers, T., Factors underlying anxiety in HIV testing: risk perceptions, stigma, and the patient-provider power dynamic. Qual. Health Res. 13:5 (2003), 636–655.
48. Zhang, L., Dailey, P.J., He, T., Gettie, A., Bonhoeffer, S., Perelson, A.S., Ho, D.D., Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques. J. Virol. 73:1 (1999), 855–860.
49. Zhang, L., Ribeiro, R.M., Mascola, J.R., Lewis, M.G., Stiegler, G., Katinger, H., Perelson, A.S., Davenport, M.P., Effects of antibody on viral kinetics in simian/human immunodeficiency virus infection: implications for vaccination. J. Virol. 78:10 (2004), 5520–5522.